nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.35	1	CpDpCtD
Tolmetin—CXCL8—chronic obstructive pulmonary disease	0.28	0.562	CbGaD
Tolmetin—MPO—chronic obstructive pulmonary disease	0.218	0.438	CbGaD
Tolmetin—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0306	1	CbGbCtD
Tolmetin—PTGS2—leg—chronic obstructive pulmonary disease	0.00181	0.123	CbGeAlD
Tolmetin—TDO2—lung—chronic obstructive pulmonary disease	0.00164	0.111	CbGeAlD
Tolmetin—CXCL8—bronchus—chronic obstructive pulmonary disease	0.0014	0.0945	CbGeAlD
Tolmetin—CXCL8—smooth muscle tissue—chronic obstructive pulmonary disease	0.00137	0.0925	CbGeAlD
Tolmetin—CXCL8—trachea—chronic obstructive pulmonary disease	0.00126	0.0849	CbGeAlD
Tolmetin—Glossitis—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.0208	CcSEcCtD
Tolmetin—MPO—respiratory system—chronic obstructive pulmonary disease	0.000994	0.0672	CbGeAlD
Tolmetin—Gastritis—Roflumilast—chronic obstructive pulmonary disease	0.000969	0.0195	CcSEcCtD
Tolmetin—CXCL8—lung—chronic obstructive pulmonary disease	0.000903	0.061	CbGeAlD
Tolmetin—MPO—connective tissue—chronic obstructive pulmonary disease	0.000875	0.0591	CbGeAlD
Tolmetin—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.000857	0.0173	CcSEcCtD
Tolmetin—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.000821	0.0165	CcSEcCtD
Tolmetin—Glossitis—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.0158	CcSEcCtD
Tolmetin—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.000766	0.0154	CcSEcCtD
Tolmetin—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.000766	0.0154	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.000755	0.0152	CcSEcCtD
Tolmetin—Zolpidem—CYP1A2—chronic obstructive pulmonary disease	0.00073	0.36	CrCbGaD
Tolmetin—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.000723	0.0146	CcSEcCtD
Tolmetin—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.000615	0.0124	CcSEcCtD
Tolmetin—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.000613	0.0124	CcSEcCtD
Tolmetin—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.0124	CcSEcCtD
Tolmetin—Indomethacin—CXCL8—chronic obstructive pulmonary disease	0.000593	0.292	CrCbGaD
Tolmetin—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.0112	CcSEcCtD
Tolmetin—Lumiracoxib—CYP1A2—chronic obstructive pulmonary disease	0.000553	0.273	CrCbGaD
Tolmetin—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000537	0.0108	CcSEcCtD
Tolmetin—MPO—lung—chronic obstructive pulmonary disease	0.000528	0.0357	CbGeAlD
Tolmetin—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.000522	0.0105	CcSEcCtD
Tolmetin—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.000517	0.0104	CcSEcCtD
Tolmetin—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.0104	CcSEcCtD
Tolmetin—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.000501	0.0101	CcSEcCtD
Tolmetin—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00992	CcSEcCtD
Tolmetin—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00992	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00049	0.00988	CcSEcCtD
Tolmetin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000474	0.00955	CcSEcCtD
Tolmetin—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000472	0.0319	CbGeAlD
Tolmetin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00046	0.00928	CcSEcCtD
Tolmetin—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000459	0.00926	CcSEcCtD
Tolmetin—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000451	0.0305	CbGeAlD
Tolmetin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00044	0.00887	CcSEcCtD
Tolmetin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000428	0.00862	CcSEcCtD
Tolmetin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000426	0.00858	CcSEcCtD
Tolmetin—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00855	CcSEcCtD
Tolmetin—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00846	CcSEcCtD
Tolmetin—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00839	CcSEcCtD
Tolmetin—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00839	CcSEcCtD
Tolmetin—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000415	0.0281	CbGeAlD
Tolmetin—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00823	CcSEcCtD
Tolmetin—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00823	CcSEcCtD
Tolmetin—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00815	CcSEcCtD
Tolmetin—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000397	0.0268	CbGeAlD
Tolmetin—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00798	CcSEcCtD
Tolmetin—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000394	0.00795	CcSEcCtD
Tolmetin—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00793	CcSEcCtD
Tolmetin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000386	0.00779	CcSEcCtD
Tolmetin—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00777	CcSEcCtD
Tolmetin—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00769	CcSEcCtD
Tolmetin—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00038	0.0257	CbGeAlD
Tolmetin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00759	CcSEcCtD
Tolmetin—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000371	0.0251	CbGeAlD
Tolmetin—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00747	CcSEcCtD
Tolmetin—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00747	CcSEcCtD
Tolmetin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000368	0.00742	CcSEcCtD
Tolmetin—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000363	0.0245	CbGeAlD
Tolmetin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000359	0.00724	CcSEcCtD
Tolmetin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00718	CcSEcCtD
Tolmetin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000356	0.00718	CcSEcCtD
Tolmetin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.00712	CcSEcCtD
Tolmetin—PTGS1—trachea—chronic obstructive pulmonary disease	0.000349	0.0235	CbGeAlD
Tolmetin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000342	0.0069	CcSEcCtD
Tolmetin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00682	CcSEcCtD
Tolmetin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00682	CcSEcCtD
Tolmetin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000337	0.0068	CcSEcCtD
Tolmetin—PTGS2—trachea—chronic obstructive pulmonary disease	0.000333	0.0225	CbGeAlD
Tolmetin—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00669	CcSEcCtD
Tolmetin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00032	0.00645	CcSEcCtD
Tolmetin—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.0064	CcSEcCtD
Tolmetin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.00637	CcSEcCtD
Tolmetin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00628	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.00627	CcSEcCtD
Tolmetin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000298	0.00601	CcSEcCtD
Tolmetin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.00592	CcSEcCtD
Tolmetin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00584	CcSEcCtD
Tolmetin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00575	CcSEcCtD
Tolmetin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00575	CcSEcCtD
Tolmetin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00575	CcSEcCtD
Tolmetin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00572	CcSEcCtD
Tolmetin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00572	CcSEcCtD
Tolmetin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.00558	CcSEcCtD
Tolmetin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00551	CcSEcCtD
Tolmetin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00551	CcSEcCtD
Tolmetin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00551	CcSEcCtD
Tolmetin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00551	CcSEcCtD
Tolmetin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00542	CcSEcCtD
Tolmetin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00542	CcSEcCtD
Tolmetin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00539	CcSEcCtD
Tolmetin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00539	CcSEcCtD
Tolmetin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00539	CcSEcCtD
Tolmetin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00528	CcSEcCtD
Tolmetin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.0052	CcSEcCtD
Tolmetin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.0052	CcSEcCtD
Tolmetin—PTGS1—lung—chronic obstructive pulmonary disease	0.00025	0.0169	CbGeAlD
Tolmetin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000246	0.00495	CcSEcCtD
Tolmetin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00493	CcSEcCtD
Tolmetin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.0049	CcSEcCtD
Tolmetin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000243	0.0049	CcSEcCtD
Tolmetin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00486	CcSEcCtD
Tolmetin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00485	CcSEcCtD
Tolmetin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00485	CcSEcCtD
Tolmetin—PTGS2—lung—chronic obstructive pulmonary disease	0.000239	0.0162	CbGeAlD
Tolmetin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000238	0.0048	CcSEcCtD
Tolmetin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000237	0.00479	CcSEcCtD
Tolmetin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00477	CcSEcCtD
Tolmetin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00475	CcSEcCtD
Tolmetin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00471	CcSEcCtD
Tolmetin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00471	CcSEcCtD
Tolmetin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00462	CcSEcCtD
Tolmetin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.0046	CcSEcCtD
Tolmetin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00458	CcSEcCtD
Tolmetin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00458	CcSEcCtD
Tolmetin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00453	CcSEcCtD
Tolmetin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000224	0.00451	CcSEcCtD
Tolmetin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000223	0.0045	CcSEcCtD
Tolmetin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.0045	CcSEcCtD
Tolmetin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00445	CcSEcCtD
Tolmetin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00441	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00441	CcSEcCtD
Tolmetin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00438	CcSEcCtD
Tolmetin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00438	CcSEcCtD
Tolmetin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00435	CcSEcCtD
Tolmetin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00435	CcSEcCtD
Tolmetin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00435	CcSEcCtD
Tolmetin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00435	CcSEcCtD
Tolmetin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000215	0.00434	CcSEcCtD
Tolmetin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.0043	CcSEcCtD
Tolmetin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00429	CcSEcCtD
Tolmetin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00428	CcSEcCtD
Tolmetin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00426	CcSEcCtD
Tolmetin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00426	CcSEcCtD
Tolmetin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00425	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.000208	0.0038	CbGpPWpGaD
Tolmetin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00413	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000205	0.00375	CbGpPWpGaD
Tolmetin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00411	CcSEcCtD
Tolmetin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00411	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.0037	CbGpPWpGaD
Tolmetin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.00405	CcSEcCtD
Tolmetin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00405	CcSEcCtD
Tolmetin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00395	CcSEcCtD
Tolmetin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00395	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—EGFR—chronic obstructive pulmonary disease	0.000193	0.00354	CbGpPWpGaD
Tolmetin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00387	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000192	0.00351	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR2—chronic obstructive pulmonary disease	0.00019	0.00348	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	0.000189	0.00346	CbGpPWpGaD
Tolmetin—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000189	0.00346	CbGpPWpGaD
Tolmetin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00377	CcSEcCtD
Tolmetin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00377	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000187	0.00343	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000185	0.00339	CbGpPWpGaD
Tolmetin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00373	CcSEcCtD
Tolmetin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00369	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000183	0.00335	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000182	0.00334	CbGpPWpGaD
Tolmetin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00364	CcSEcCtD
Tolmetin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00364	CcSEcCtD
Tolmetin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00357	CcSEcCtD
Tolmetin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00356	CcSEcCtD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—TGFB1—chronic obstructive pulmonary disease	0.000175	0.00321	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.000174	0.00319	CbGpPWpGaD
Tolmetin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.0035	CcSEcCtD
Tolmetin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000174	0.0035	CcSEcCtD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000173	0.00316	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00316	CbGpPWpGaD
Tolmetin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00347	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000171	0.00314	CbGpPWpGaD
Tolmetin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00345	CcSEcCtD
Tolmetin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00345	CcSEcCtD
Tolmetin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00345	CcSEcCtD
Tolmetin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00344	CcSEcCtD
Tolmetin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00343	CcSEcCtD
Tolmetin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00338	CcSEcCtD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000167	0.00307	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000167	0.00306	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00305	CbGpPWpGaD
Tolmetin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00331	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.000163	0.00299	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—TP53—chronic obstructive pulmonary disease	0.000162	0.00297	CbGpPWpGaD
Tolmetin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00327	CcSEcCtD
Tolmetin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00327	CcSEcCtD
Tolmetin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00326	CcSEcCtD
Tolmetin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.00016	0.00293	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000159	0.00292	CbGpPWpGaD
Tolmetin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000159	0.0032	CcSEcCtD
Tolmetin—TDO2—Metabolism—GC—chronic obstructive pulmonary disease	0.000155	0.00284	CbGpPWpGaD
Tolmetin—Indomethacin—ALB—chronic obstructive pulmonary disease	0.000154	0.0759	CrCbGaD
Tolmetin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00309	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000153	0.0028	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—PLAU—chronic obstructive pulmonary disease	0.000152	0.00279	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TLR4—chronic obstructive pulmonary disease	0.00015	0.00276	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.00015	0.00275	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000149	0.00273	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000149	0.00272	CbGpPWpGaD
Tolmetin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00298	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00298	CcSEcCtD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000147	0.0027	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000147	0.00269	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00268	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000146	0.00268	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000144	0.00264	CbGpPWpGaD
Tolmetin—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000139	0.00255	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000138	0.00252	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000137	0.00252	CbGpPWpGaD
Tolmetin—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00251	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000137	0.00251	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000137	0.0025	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000136	0.00249	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000135	0.00247	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—MMP9—chronic obstructive pulmonary disease	0.000134	0.00246	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000134	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000133	0.00243	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—chronic obstructive pulmonary disease	0.000129	0.00236	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000127	0.00233	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000126	0.0023	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000125	0.00229	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000125	0.00229	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000121	0.00222	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00222	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.00012	0.0022	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.00012	0.00219	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000119	0.00219	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—SERPINE1—chronic obstructive pulmonary disease	0.000118	0.00216	CbGpPWpGaD
Tolmetin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00237	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000118	0.00215	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR4—chronic obstructive pulmonary disease	0.000117	0.00215	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000117	0.00215	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000115	0.0021	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000112	0.00205	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000109	0.00201	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—EGFR—chronic obstructive pulmonary disease	0.000108	0.00198	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000108	0.00197	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00217	CcSEcCtD
Tolmetin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00217	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000107	0.00195	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00195	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000105	0.00193	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000105	0.00192	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.000103	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000102	0.00186	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	9.79e-05	0.00179	CbGpPWpGaD
Tolmetin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.79e-05	0.00197	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	9.74e-05	0.00179	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	9.63e-05	0.00176	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1B—chronic obstructive pulmonary disease	9.56e-05	0.00175	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	9.55e-05	0.00175	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	9.49e-05	0.00174	CbGpPWpGaD
Tolmetin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.00191	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	9.33e-05	0.00171	CbGpPWpGaD
Tolmetin—Headache—Prednisolone—chronic obstructive pulmonary disease	9.27e-05	0.00187	CcSEcCtD
Tolmetin—Constipation—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.00185	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	8.88e-05	0.00163	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.85e-05	0.00162	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.00177	CcSEcCtD
Tolmetin—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.79e-05	0.00177	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.71e-05	0.0016	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	8.71e-05	0.0016	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	8.7e-05	0.00159	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	8.62e-05	0.00158	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.57e-05	0.00157	CbGpPWpGaD
Tolmetin—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.00172	CcSEcCtD
Tolmetin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00171	CcSEcCtD
Tolmetin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00171	CcSEcCtD
Tolmetin—TDO2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.47e-05	0.00155	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	8.46e-05	0.00155	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.37e-05	0.00153	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	8.26e-05	0.00151	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	8.21e-05	0.0015	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	7.91e-05	0.00145	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	7.75e-05	0.00142	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	7.73e-05	0.00142	CbGpPWpGaD
Tolmetin—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.00156	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	7.7e-05	0.00141	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	7.64e-05	0.0014	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.64e-05	0.0014	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.48e-05	0.00137	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.48e-05	0.00137	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	7.47e-05	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	7.46e-05	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TGFB1—chronic obstructive pulmonary disease	7.43e-05	0.00136	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.38e-05	0.00135	CbGpPWpGaD
Tolmetin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.00148	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.33e-05	0.00134	CbGpPWpGaD
Tolmetin—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.11e-05	0.00143	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—chronic obstructive pulmonary disease	7.1e-05	0.0013	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.04e-05	0.00129	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.97e-05	0.00128	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.86e-05	0.00126	CbGpPWpGaD
Tolmetin—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.00138	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	6.82e-05	0.00125	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.78e-05	0.00124	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	6.77e-05	0.00124	CbGpPWpGaD
Tolmetin—Headache—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.00136	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.73e-05	0.00123	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.66e-05	0.00122	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	6.64e-05	0.00122	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.56e-05	0.0012	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	6.45e-05	0.00118	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.43e-05	0.00118	CbGpPWpGaD
Tolmetin—Nausea—Prednisone—chronic obstructive pulmonary disease	6.39e-05	0.00129	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	6.32e-05	0.00116	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.18e-05	0.00113	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	6.12e-05	0.00112	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6.08e-05	0.00111	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	5.99e-05	0.0011	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.94e-05	0.00109	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.94e-05	0.00109	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	5.93e-05	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.91e-05	0.00108	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.9e-05	0.00108	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.88e-05	0.00108	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.87e-05	0.00108	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	5.86e-05	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.86e-05	0.00107	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.79e-05	0.00106	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	5.73e-05	0.00105	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	5.6e-05	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—chronic obstructive pulmonary disease	5.6e-05	0.00103	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	5.58e-05	0.00102	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	5.57e-05	0.00102	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	5.54e-05	0.00102	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	5.5e-05	0.00101	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	5.4e-05	0.000989	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.39e-05	0.000988	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.37e-05	0.000983	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.19e-05	0.000951	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	5.17e-05	0.000947	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.13e-05	0.00094	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.11e-05	0.000937	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	5.1e-05	0.000935	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.06e-05	0.000926	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	4.85e-05	0.000889	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.83e-05	0.000884	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	4.47e-05	0.00082	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.41e-05	0.000808	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	4.1e-05	0.000752	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.08e-05	0.000748	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	3.98e-05	0.000729	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.93e-05	0.000721	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.88e-05	0.000711	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	3.87e-05	0.00071	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—chronic obstructive pulmonary disease	3.87e-05	0.000709	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	3.82e-05	0.000699	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.71e-05	0.000679	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.69e-05	0.000675	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	3.6e-05	0.000659	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.56e-05	0.000652	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—chronic obstructive pulmonary disease	3.54e-05	0.000649	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.5e-05	0.000642	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALB—chronic obstructive pulmonary disease	3.48e-05	0.000637	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	3.47e-05	0.000635	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.42e-05	0.000628	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.4e-05	0.000622	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.37e-05	0.000617	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	3.35e-05	0.000615	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.33e-05	0.00061	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.32e-05	0.000609	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.31e-05	0.000607	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.28e-05	0.000601	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.17e-05	0.000581	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.1e-05	0.000568	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.01e-05	0.000551	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.97e-05	0.000543	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.93e-05	0.000536	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	2.93e-05	0.000536	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.91e-05	0.000533	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.9e-05	0.000531	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.83e-05	0.000518	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.77e-05	0.000507	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.72e-05	0.000498	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.7e-05	0.000494	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	2.68e-05	0.000491	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.64e-05	0.000485	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.63e-05	0.000482	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.000452	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.46e-05	0.000451	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.44e-05	0.000447	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.32e-05	0.000425	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.23e-05	0.000409	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.2e-05	0.000403	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.16e-05	0.000395	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.02e-05	0.00037	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.99e-05	0.000364	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.98e-05	0.000362	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.97e-05	0.000361	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.96e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.88e-05	0.000345	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000334	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.8e-05	0.00033	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.78e-05	0.000326	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000307	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.66e-05	0.000304	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.000301	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.62e-05	0.000296	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.55e-05	0.000285	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.000277	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.45e-05	0.000266	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.45e-05	0.000265	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.44e-05	0.000265	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.43e-05	0.000262	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.35e-05	0.000247	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000244	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.3e-05	0.000239	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000231	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.24e-05	0.000228	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.00022	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.000218	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.000212	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.13e-05	0.000208	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000201	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.000198	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.01e-05	0.000185	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1e-05	0.000184	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.88e-06	0.000181	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.2e-06	0.000169	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.13e-06	0.000167	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.72e-06	0.00016	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.69e-06	0.000159	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	8.43e-06	0.000154	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.8e-06	0.000143	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.47e-06	0.000137	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.16e-06	0.000131	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.15e-06	0.000131	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	7.1e-06	0.00013	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.02e-06	0.000129	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	6.77e-06	0.000124	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	5.93e-06	0.000109	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.89e-06	0.000108	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.67e-06	0.000104	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.4e-06	9.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	4.48e-06	8.21e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	4.39e-06	8.05e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	3.38e-06	6.18e-05	CbGpPWpGaD
